Methysticin, a naturally occurring inhibitor of NFkB signaling [46], repressed ZFAS1 while simultaneously upregulating ZNFX1 in a dose-dependent manner in cultured A549 lung cancer cells (Fig. 11E). The gene discussed is NFKB1; the disease is lung carcinoma.